CPME WG on Pharmaceuticals – Chairperson: Dr Erzsébet Podmaniczky (HU)
CPME Secretariat: Carole Rouaud, EU Policy Adviser
CPME has had a long standing involvement on issues related to pharmaceuticals. Currently, CPME participates actively in the European Medicines Agency (EMA)’s activities, as member of the EMA Management Board and of the Healthcare professional Working Party (HCPWP) during the 2016-2019 mandate.
CPME is represented in the following bodies and expert groups by :
- EMA Management Board – CPME Representative : Prof. Wolf-Dieter Ludwig (DE)
- EMA Healthcare Professionals’ Working Party – CPME Representative: Dr Erzsébet Podmaniczky (HU)
Adopted policies include:
- CPME policy on off-label use of medicinal products, adopted in April 2017
- CPME policy on medication – Interprofessional collaboration between doctors and pharmacists, adopted in November 2016
- CPME response to the EMA Good practice guides on medication errors, adopted in June 2015
- CPME position paper on rules regarding expiration dates of pharmaceuticals, adopted in May 2015
